EP2046331
Notkun á 3-(4-amínó-1-oxó-1,3-díhýdró-isoindol-2-ýl)-piperidín-2,6-díon til meðhöndlunar á möttulfrumukrabbameini í eitlum.
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.8.2007EP published:
3.11.2010EP application number:
07811048.3
EP translation filed:
22.2.2011Grant published:
15.3.2011EPO information:
European Patent Register
Max expiry date:
1.8.2027Expiry date:
1.8.2026Next due date:
31.8.2026
Title:
USE OF 3- (4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF MANTLE CELL LYMPHOMAS
Timeline
Owner
Name:
CELGENE CORPORATIONAddress:
86 Morris Avenue, 07901, Summit, NJ, US
Inventor
Name:
ZELDIS, Jerome, B.Address:
Princeton, NJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
835752 PDate:
3.8.2006Country:
US
Classification
Categories:
A61K 31/454, A61K 39/395, A61K 45/06, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 21.7.2011
Expires: 1.8.2012
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 19.7.2012
Expires: 1.8.2013
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 18.7.2013
Expires: 1.8.2014
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.7.2014
Expires: 1.8.2015
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 17.7.2015
Expires: 1.8.2016
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 19.7.2016
Expires: 1.8.2017
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 19.7.2017
Expires: 1.8.2018
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 18.7.2018
Expires: 1.8.2019
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 18.7.2019
Expires: 1.8.2020
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 8.7.2020
Expires: 1.8.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.7.2021
Expires: 1.8.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 5.7.2022
Expires: 1.8.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 11.7.2023
Expires: 1.8.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 9.7.2024
Expires: 1.8.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 18.7.2025
Expires: 1.8.2026
Payer: Árnason Faktor ehf.